Dominique Mathieu1, Charles Martel1, Marie-Pierre Campeau1, Édith Filion1, David Roberge2, Houda Bahig1, Toni Vu1, Louise Lambert1, Karim Boudam3, Jean-Francois Carrier1. 1. Department of Radiation Oncology, Centre hospitalier de l'université de Montréal (CHUM). 2. Department of Oncology, Division of Radiation Oncology, McGill University Health Center ; Department of Radiology, Radiation Oncology and Nuclear Medicine, University of Montreal ; Department of Radiation Oncology, Centre hospitalier de l'université de Montréal (CHUM) ; Department of Oncology, Division of Radiation Oncology, McGill University Health Center. 3. Department of Radiation Oncology, Centre hospitalier de l'Université de Montréal (CHUM).
Abstract
PURPOSE: The objectives of this study are (1) to measure concordance of tumor position on breath-hold (BH) computed tomography (CT) scans relative to the natural tumor path during free breathing (FB) and (2) to evaluate the benefits of the breathing monitoring device Abches (Apex Medical, Tokyo) for stereotactic ablative radiotherapy (SABR) treatment planning. METHODS: In 53 lung cancer patients treated with CyberKnife™ robotic radiosurgery system, FB four-dimensional computerized tomography (4DCT) and end-expiration (EE) BH CT images were obtained. Extent of natural tumor motion was assessed with rigid registration derived from end-inspiration (EI) and EE phases of the 4DCT. Tumor displacement in BH scans relative to the natural tumor path was measured relative to the EE 4DCT phase. RESULTS: Mean tumor motion (+/- 1 SD) during natural FB was 1 ± 1 mm, 2 ± 2 mm, and 6 ± 6 mm in medio-lateral, anterior-posterior, and cranio-caudal directions, respectively. Tumor position on BH CT scan was closer to EE than EI 4DCT phase for 35/53 patients (66%). Difference of BH tumor position vs. EE state was 4 ± 3 mm. Gross tumor displacements perpendicular to natural tumor path were as great as 11 mm (anterior-posterior) and were seen with or without the breathing monitoring device. CONCLUSION: Tumor position during BH CT may not accurately correspond to positions observed on FB 4DCT. Hence, accurate and custom 4D analysis for each individual patient is recommended for treatment planning, especially those involving BH acquisitions.
PURPOSE: The objectives of this study are (1) to measure concordance of tumor position on breath-hold (BH) computed tomography (CT) scans relative to the natural tumor path during free breathing (FB) and (2) to evaluate the benefits of the breathing monitoring device Abches (Apex Medical, Tokyo) for stereotactic ablative radiotherapy (SABR) treatment planning. METHODS: In 53 lung cancerpatients treated with CyberKnife™ robotic radiosurgery system, FB four-dimensional computerized tomography (4DCT) and end-expiration (EE) BH CT images were obtained. Extent of natural tumor motion was assessed with rigid registration derived from end-inspiration (EI) and EE phases of the 4DCT. Tumor displacement in BH scans relative to the natural tumor path was measured relative to the EE 4DCT phase. RESULTS: Mean tumor motion (+/- 1 SD) during natural FB was 1 ± 1 mm, 2 ± 2 mm, and 6 ± 6 mm in medio-lateral, anterior-posterior, and cranio-caudal directions, respectively. Tumor position on BH CT scan was closer to EE than EI 4DCT phase for 35/53 patients (66%). Difference of BH tumor position vs. EE state was 4 ± 3 mm. Gross tumor displacements perpendicular to natural tumor path were as great as 11 mm (anterior-posterior) and were seen with or without the breathing monitoring device. CONCLUSION:Tumor position during BH CT may not accurately correspond to positions observed on FB 4DCT. Hence, accurate and custom 4D analysis for each individual patient is recommended for treatment planning, especially those involving BH acquisitions.
Authors: Christian Plathow; Sebastian Ley; Christian Fink; Michael Puderbach; Waldemar Hosch; Astrid Schmähl; Jürgen Debus; Hans-Ulrich Kauczor Journal: Int J Radiat Oncol Biol Phys Date: 2004-07-15 Impact factor: 7.038
Authors: H Helen Liu; Peter Balter; Teresa Tutt; Bum Choi; Joy Zhang; Catherine Wang; Melinda Chi; Dershan Luo; Tinsu Pan; Sandeep Hunjan; George Starkschall; Isaac Rosen; Karl Prado; Zhongxing Liao; Joe Chang; Ritsuko Komaki; James D Cox; Radhe Mohan; Lei Dong Journal: Int J Radiat Oncol Biol Phys Date: 2007-03-29 Impact factor: 7.038
Authors: Lu Wang; Shelly Hayes; Kamen Paskalev; Lihui Jin; Mark K Buyyounouski; Charlie C-M Ma; Steve Feigenberg Journal: Radiother Oncol Date: 2008-12-26 Impact factor: 6.280
Authors: Ha Yoon Lee; Jee Suk Chang; Ik Jae Lee; Kwangwoo Park; Yong Bae Kim; Chang Ok Suh; Jun Won Kim; Ki Chang Keum Journal: Radiat Oncol J Date: 2013-12-31